Home Courts Regeneron facing patent infringement suit over Covid-19 treatment

Regeneron facing patent infringement suit over Covid-19 treatment

SHARE

Regeneron Pharmaceuticals is one of three pharma companies that stand accused of patent infringement, in lawsuits alleging the unlawful use of a technology used in their respective Covid-19 treatments.   According to suits filed by San Diego’s Allele Biotechnology & Pharmaceuticals Inc. – one against Tarrytown-based Regeneron, and the other against New York City-based Pfizer…

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.
Print Friendly, PDF & Email